Back
Viridian Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
33
VRDN
Viridian Therapeutics, Inc.
Last Price:
$18.82
Seasonality Move:
6.62%
7 Day Trial
ALL ACCESS PASS
$
7
Viridian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 2.8% based on the past 11 years of stock performance.
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
-
Is Viridian Therapeutics, Inc. Stock Undervalued?The current Viridian Therapeutics, Inc. [VRDN] share price is $18.84. The Score for VRDN is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
-
VRDN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Viridian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Viridian Therapeutics, Inc. has on average historically fallen by 2.8% based on the past 11 years of stock performance.
Viridian Therapeutics, Inc. Stock Rating
Sell
33
Viridian Therapeutics, Inc. (VRDN)
is a Sell
Is Viridian Therapeutics, Inc. overpriced?
-
Viridian Therapeutics, Inc. has fallen lower in 6 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 54.55%
Viridian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
viridiantherapeutics.com
52-Week Data
52-Week High:
34.29
52-Week Low:
9.90
Prediction Charts
Market Cap:
1.9B
Price in USD:
18.84
Volume:
3M
Beta:
1.31
Technical Analysis
SMA50:
28.72
SMA100:
29.95
SMA200:
24.45
52-Wk Change:
44.15%
Stock Predictions
-
Is Viridian Therapeutics, Inc. stock public?Yes, Viridian Therapeutics, Inc. is a publicly traded company.
-
What is the Viridian Therapeutics, Inc. stock quote today?The Viridian Therapeutics, Inc. stock price is 18.84 USD today.
-
How to buy Viridian Therapeutics, Inc. stock online?You can buy Viridian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 29.00 | 28.77 | 29.19 | 28.52 |
| Mar-17 | 28.72 | 28.60 | 29.32 | 28.48 |
| Mar-18 | 28.36 | 27.73 | 28.45 | 27.00 |
| Mar-19 | 27.69 | 27.84 | 28.14 | 27.18 |
| Mar-20 | 27.83 | 26.98 | 28.10 | 26.95 |
| Mar-23 | 27.62 | 27.62 | 28.30 | 27.25 |
| Mar-24 | 27.02 | 27.19 | 27.48 | 26.28 |
| Mar-25 | 27.24 | 28.35 | 28.59 | 27.10 |
| Mar-26 | 27.84 | 28.20 | 28.37 | 27.50 |
| Mar-27 | 27.86 | 27.39 | 28.19 | 27.29 |
| Mar-30 | 17.00 | 18.53 | 19.10 | 16.97 |
| Mar-31 | 18.71 | 19.56 | 19.84 | 18.49 |
| Apr-1 | 19.74 | 19.15 | 19.74 | 18.93 |
| Apr-2 | 18.56 | 18.84 | 19.25 | 18.44 |
Viridian Therapeutics, Inc. Earnings
Viridian Therapeutics, Inc. Earnings Report: Per Share Viridian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Viridian Therapeutics, Inc. Forecast Revenue Growth
Viridian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Viridian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.13 per share, a decrease this year of $0.31 per share, and an increase next year of $1.66 per share.
* Viridian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.